Susan Morse
While AI is spurring success, barriers to treatment remain, says Daniella Gilboa, CEO of AIVF.
Bronwyn Spira is CEO and cofounder of Force Therapeutics, a digital care management platform for musculoskeletal conditions.
If approved, Bertagnolli would oversee a $47B annual budget that funds biomedical research linked to half of the drugs approved by the FDA.
The movement to a modern infrastructure means rethinking business processes to allow more time for clinical care, says Rich Birhanzel of Accenture.
"The end of the COVID-19 public health emergency marks a tremendous transition for our country, for public health, and in my tenure as CDC Director."
HIMSS23 keynote speaker Salim Ismail, founder and chair of OpenExO, talks about the decade of Exponential Organizations.
Sharing patient information electronically from a hospital to post-acute care is not widespread, providers told CMS.
Changes in reimbursement and payment policies are impacting remote patient monitoring.
"We've been working very hard to understand how can healthcare come back," says Jonathan Blum of CMS.